Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $51.7800 (3.2%) ($50.5200 - $51.7800) on Fri. Jul. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 79 | Latest Price | $51.7800(3.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 3.4% a day on average for past five trading days. | Weekly Trend | HALO advances 3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(44%) IWO(39%) IWM(38%) IWN(37%) IWC(36%) | Factors Impacting HALO price | HALO will decline at least -1.295% in a week (0% probabilities). VIXM(-15%) UUP(-8%) VXX(-6%) TBT(-2%) TLT(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $47.87(8.17%) | 10 Day Moving Average | $46.92(10.36%) | 20 Day Moving Average | $45.81(13.03%) | To recent high | 0% | To recent low | 38.6% | Market Cap | $7.077b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |